Overview
Aarey Drugs & Pharmaceuticals Ltd, founded in 1990, manufactures and supplies pharmaceutical raw materials, chemicals, and API drugs.
The company underwent a significant transition in 1993 when the Aarey Group took over and rebranded the company from Niharika Textiles & Chemicals.
Aarey Drugs produces pharmaceutical products compliant with IP/BP/CP/USP standards, indicating high-quality assurance and adherence to international regulatory standards.
In 2009 and 2016, the company upgraded and diversified its manufacturing capabilities, including new products like Mono Methyl Urea and Erithromycin Derivatives.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
260 Cr
- Volatility
High Risk
- P/E Ratio
57.6
- Industry P/E
35.1
- PEG Ratio
-25.7
- P/B Ratio
1.7
- 52W High
100.00
- 52W Low
50.40
Financial Ratios
Sales CAGR
- 1Y
- 19.80%
- 3Y
- -1.29%
- 5Y
- 9.57%
- 10Y
- 7.56%
Profit CAGR
- 1Y
- -14.10%
- 3Y
- -15.01%
- 5Y
- -7.03%
- 10Y
- 13.48%
ROE
- TTM
- 2.64%
- 3Y
- 3.21%
- 5Y
- 4.25%
- 10Y
- 5.37%
ROCE
- TTM
- 5.20%
- 3Y
- 7.32%
- 5Y
- 8.39%
- 10Y
- 10.11%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
